Cargando…

Durability and Long-Term Clinical Outcomes of Fecal Microbiota Transplant (FMT) Treatment in Patients with Recurrent C. difficile Infection

BACKGROUND: Fecal microbiota transplant (FMT) has been shown to be safe and effective for treatment of recurrent C. difficile infection (RCDI). The aim of this study is to determine factors impacting the durability of FMT and assess patient long-term clinical outcomes and satisfaction with the proce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mamo, Yafet, Woodworth, Michael, Sitchenko, Kaitlin, Dhere, Tanvi, Kraft, Colleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630940/ http://dx.doi.org/10.1093/ofid/ofx163.954

Ejemplares similares

Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections
por: Wang, Tiffany, et al.
Publicado: (2018)

Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
por: Steed, Danielle Barrios, et al.
Publicado: (2020)

109. Differences in Gram-Negative Antibiotic Susceptibility Among Patients Receiving Fecal Microbiota Transplant for Clostridioides difficile
por: Woodworth, Michael, et al.
Publicado: (2018)

Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
por: Youngster, Ilan, et al.
Publicado: (2016)

Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection
por: Garza-González, Elvira, et al.
Publicado: (2019)

Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
por: Fareed, Shaaz, et al.
Publicado: (2018)

1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)
por: Hassoun, Ali, et al.
Publicado: (2018)

1929. Evaluating Disparities in Recurrent Clostridioides difficile Infection (CDI) and Fecal Microbiota Transplant (FMT) Treatment using Geospatial and Social Vulnerability Analytic Tools
por: Little, Keighly, et al.
Publicado: (2023)

Step-up fecal microbiota transplantation (FMT) strategy
por: Cui, Bota, et al.
Publicado: (2016)

Monkeypox and fecal microbiota for transplantation(FMT): An unprecedented risk?
por: Owais, Rabia, et al.
Publicado: (2022)

Fecal Microbiota Transplantation (FMT) for Recurrent/Refractory Clostridium difficile Infection (CDI) in Pediatric Immunocompromised Patients: A Single-center Experience
por: Kwendakwema, Natasha, et al.
Publicado: (2017)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection
por: Chehri, Mahtab, et al.
Publicado: (2018)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression—Case Report
por: Doll, Jessica P. K., et al.
Publicado: (2022)

Effectiveness of FMT in recurrent Clostridium difficile infection
por: Grzesiowski, P, et al.
Publicado: (2015)

Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides difficile Infection. Is There a Role of FMT in Primary Severe CDI?
por: Popa, Daniel, et al.
Publicado: (2021)

Clinical and Economic Evaluation of commercialized Fecal Microbiota Transplant (cFMT) for Patients with Recurrent Clostridium difficile Infection (CDI) in a Large Community Hospital
por: Hassoun, Ali, et al.
Publicado: (2017)

Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation
por: Zhang, Wanying, et al.
Publicado: (2020)

615. Can We Restore the Lung Microbiome with Fecal Microbiota Transplant (FMT)?
por: Mendez, Roberto, et al.
Publicado: (2018)

2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Saha, Srishti, et al.
Publicado: (2019)

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D
por: Singh, Prashant, et al.
Publicado: (2022)

Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection
por: Staley, Christopher, et al.
Publicado: (2019)

Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series
por: Dang, Xiao-Fei, et al.
Publicado: (2020)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
por: Yu, Elaine W., et al.
Publicado: (2020)

Knowledge, attitudes, ethical and social perspectives towards fecal microbiota transplantation (FMT) among Jordanian healthcare providers
por: Al-Bakri, Amal G., et al.
Publicado: (2021)

A48 LYOPHILIZED FECAL MICROBIOTA TRANSPLANT (FMT) DELAYS THE ONSET OF SPONTANEOUS COLITIS IN MUC2-/- MICE
por: Chan, J J, et al.
Publicado: (2023)

Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Song, Yang, et al.
Publicado: (2013)

Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results
por: Reigadas, Elena, et al.
Publicado: (2018)

Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
por: Staley, Christopher, et al.
Publicado: (2018)

Fecal Microbiota Transplant in Recurrent Clostridium Difficile Infections: A Systematic Review
por: Gupta, Kunal, et al.
Publicado: (2022)

312. Strain Engraftment and Gene Transfer in a Fecal Microbiota Transplantation Cohort
por: Brink, Catherine, et al.
Publicado: (2023)

Correction: Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Publicado: (2014)

1654 Fecal Microbiota Transplant for the Treatment of Recurrent Clostridium difficile Infection via Encapsulated Cryopreserved Concentrated Fecally Derived Bacteria: A Cohort Review
por: Saraiya, Nimit, et al.
Publicado: (2014)

Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent Clostridium difficile Infection
por: Hecker, Michelle T., et al.
Publicado: (2016)

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lgqp8kflj6613ed2kpaf2qd953